Moolec Science
MLEC
4 hedge funds and large institutions have $91.7K invested in Moolec Science in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
41% more capital invested
Capital invested by funds: $64.9K → $91.7K (+$26.9K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Penserra Capital Management
Orinda,
California
|
+$5.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.17K |
| 2 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
-$1.7K |
MLEC Hedge Fund Activity: Q2 2023 in Review
4 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Moolec Science (MLEC) for Q2 2023, worth a combined $91.7K — up 41% from $64.9K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MLEC and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Penserra Capital Management, opening a new position worth an estimated $5.36K. The largest seller was UBS Group, exiting entirely with an estimated $7.17K sold.
- 4 institutional investors held Moolec Science (MLEC) as of Q2 2023, down from 5 in Q1 2023.
- Funds reported $91.7K of Moolec Science stock for Q2 2023, up 41% quarter-over-quarter.
- 1 fund opened new Moolec Science positions in Q2 2023 and 2 closed out, a net change of -1 holder.
- The largest Moolec Science buyer in Q2 2023 was Penserra Capital Management, an estimated $5.36K added.
- The largest Moolec Science seller in Q2 2023 was UBS Group, an estimated $7.17K sold.
Based on aggregated 13F filings for Q2 2023.